{"id":3569,"date":"2017-12-11T17:00:20","date_gmt":"2017-12-11T22:00:20","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3569"},"modified":"2017-12-11T17:00:20","modified_gmt":"2017-12-11T22:00:20","slug":"secondary-offerings-announced-12-11-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondary-offerings-announced-12-11-17\/","title":{"rendered":"Secondary offerings Announced 12.11.17"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n

Company: bluebird bio
\nSymbol: BLUE
\nPrice: Last Trade $201.80
\nTrade Date: 12\/13
\nShares: 2.95 million ($600 milion cash raise)
\nUnderwriter(s) : Goldman Sachs, BofA Merrill Lynch, J.P. Morgan, Cowen
\nDescription: With its lentiviral-based gene therapies, T cell immunotherapy expertise and gene editing capabilities, bluebird bio has built an integrated product platform with broad potential application to severe genetic diseases and cancer.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Blueprint Medicines Corporation
\nSymbol: BPMC
\nPrice: Last Trade $88.32
\nTrade Date: 12\/13
\nShares: 3.1 million ($275 million cash raise)
\nUnderwriter(s) : Goldman Sachs, Morgan Stanley, Cowen
\nDescription: Blueprint Medicines is developing a new generation of targeted and potent kinase medicines to improve the lives of patients with genomically defined diseases.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Acer Therapeutics, Inc.
\nSymbol: ACER
\nPrice: Last Trade $14.15
\nTrade Date: 12\/12
\nShares: 0.76 million $10 million cash raise
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : William Blair
\nDescription: They are a a pharmaceutical company focused on the acquisition, development and commercialization of therapies for patients with serious rare and ultra-rare diseases with critical unmet medical need.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Oasis Petroleum, Inc.
\nSymbol: OAS
\nPrice: Last Trade $10.06
\nTrade Date: 12\/12
\nShares: 32 million
\nRe-Offer Range:\u00a0Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Goldman Sachs, Credit Suisse
\nDescription: Oasis Petroleum is an independent exploration and production company focused on the acquisition and development of unconventional oil and natural gas resources, primarily operating in the Williston and Delaware Basins.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Hyatt Hotels Corporation – Block
\nSymbol: H
\nPrice: Last Trade $71.90
\nTrade Date: 12\/12
\nShares: 2.7 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Morgan Stanley
\nDescription: Hyatt Hotels Corporation, a hospitality company, develops, owns, operates, manages, franchises, licenses, or provides services to full and select service hotels, resorts, and residential and other properties.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: argenx
\nSymbol: ARGX
\nPrice: Last Trade $54.47
\nTrade Date: 12\/13
\nShares: 2.8 million ($150 million cash raise)
\nUnderwriter(s) : Cowen, Piper Jaffray
\nCo-Manager(s): JMP Securities, Wedbush PacGrow
\nDescription: Argenx is a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Unitil Corporation
\nSymbol: UTL
\nPrice: Last Trade $49.78
\nTrade Date: 12\/12
\nShares: 0.6 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): RBC Capital Markets, BofA Merrill Lynch
\nJanney Montgomery Scott
\nDescription: They are a public utility holding company.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: GMS, Inc.-BLOCK
\nSymbol: GMS
\nPrice: Last Trade $38.97
\nTrade Date: 12\/12
\nShares: 5 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Morgan Stanley
\nDescription:Founded in 1971, GMS operates a network of more than 210 distribution centers across the United States.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: The Providence Service Corporation — BLOCK
\nSymbol: PRSC
\nPrice: Last Trade $58.26
\nTrade Date: 12\/12
\nShares: 0.32 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Jefferies
\nDescription: The Providence Service Corporation, through its subsidiaries, provides critical healthcare and workforce development services for public and private sector entities in the United States and internationally.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: NCI Building Systems, Inc.
\nSymbol: NCS
\nPrice: Last Trade $20.60
\nTrade Date: 12\/12
\nShares: 7.15 million
\nRe-Offer Range:Subscription Needed<\/a><\/strong>
\nUnderwriter(s) : Goldman Sachs, RBC Capital
\nDescription: NCI Building Systems, Inc. is one of North America’s largest integrated manufacturers and marketers of metal products for the nonresidential construction industry.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Iron Mountain Incorporated
\nSymbol: IRM
\nPrice: Last Trade $40.70
\nTrade Date: 12\/13
\nShares: 14.5 million
\nUnderwriter(s) : J.P. Morgan, BofA Merrill Lynch, Wells Fargo Securities, Barclays, Evercore ISI
\nDescription: Iron Mountain Incorporated is the global leader for storage and information management services.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[],"class_list":["post-3569","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3569","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3569"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3569\/revisions"}],"predecessor-version":[{"id":3571,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3569\/revisions\/3571"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3569"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3569"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3569"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}